Clinical Breast Cancer


Publication Venue For

  • Characterizing Clinicopathologic Features of Estrogen Receptor-Positive/Progesterone Receptor-Negative Breast Cancers.  22:e788-e797. 2022
  • Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study.  22:e463-e472. 2022
  • Discordance Between Immunohistochemistry and In Situ Hybridization to Detect HER2 Overexpression/Gene Amplification in Breast Cancer in the Modern Age: A Single Institution Experience and Pooled Literature Review Study: Discordance between HER2 overexpression and gene amplification in breast cancer.  22:e123-e133. 2022
  • Utilizing Data Visualization to Identify Survival and Treatment Differences Between Women With De Novo and Recurrent Metastatic Breast Cancer.  21:292-301. 2021
  • Treatment Decision Making and Financial Toxicity in Women With Metastatic Breast Cancer.  21:37-46. 2021
  • RANKLed by the Complexity of Signaling in Breast Cancer Metastasis to the Brain.  20:e569-e575. 2020
  • Comparison of Radioactive Seed Localized Excision and Wire Localized Excision of Breast Lesions: A Community Hospital's Experience.  19:e364-e369. 2019
  • Comparison of AJCC Anatomic and Clinical Prognostic Stage Groups in Breast Cancer: Analysis of 3322 Cases From a Single Institution.  18:e1347-e1352. 2018
  • Invasive Breast Carcinoma Tumor Size on Core Needle Biopsy: Analysis of Practice Patterns and Effect on Final Pathologic Tumor Stage.  18:e1027-e1030. 2018
  • Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases..  18:298-304. 2018
  • Grade and prognosis in localized primary angiosarcoma.  15:266-269. 2015
  • Characteristics of breast carcinoma cases with false-negative sentinel lymph nodes.  14:280-284. 2014
  • Accuracy of breast magnetic resonance imaging in predicting pathologic response in patients treated with neoadjuvant chemotherapy.  11:312-319. 2011
  • Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: A phase III, randomized, open-label trial.  11:82-92. 2011
  • Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer.  10:281-287. 2010
  • Pilot trial of preoperative (Neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor-or progesterone receptor-positive breast cancer.  10:275-280. 2010
  • Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy.  8:70-79. 2008
  • International Standard Serial Number (issn)

  • 1526-8209
  • Electronic International Standard Serial Number (eissn)

  • 1938-0666